%PDF-1.4
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-05-29T17:49:25+02:00
2013-05-29T15:48:44Z
2013-05-29T17:49:25+02:00
Microsoft Word
uuid:98c0d9c2-0c1a-5a44-84d7-f45af6f9f562
uuid:1a80a60b-d634-3345-b824-3fb4c0e9a718
application/pdf
Microsoft Word - PhD_thesis_Thorsten_Klampfl.docx
Thorsten
Adobe Mac PDF Plug-in
1
B
http://ns.adobe.com/xap/1.0/mm/
xmpMM
XMP Media Management Schema
internal
UUID based identifier for specific incarnation of a document
InstanceID
URI
http://www.aiim.org/pdfa/ns/id/
pdfaid
PDF/A ID Schema
internal
Part of PDF/A standard
part
Integer
internal
Amendment of PDF/A standard
amd
Text
internal
Conformance level of PDF/A standard
conformance
Text
endstream
endobj
5 0 obj
[<>]
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
8 0 obj
<>
endobj
9 0 obj
<>
endobj
10 0 obj
<>
endobj
26 0 obj
<>
endobj
27 0 obj
<>
endobj
28 0 obj
<>
endobj
29 0 obj
<>
endobj
30 0 obj
<>
endobj
51 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
52 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
53 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
54 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
55 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
56 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
57 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
58 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
59 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
77 0 obj
<>stream
BT
/CS0 cs 0 0 0 scn
/GS0 gs
/C2_0 1 Tf
12 0 0 12 72.059 795.021 Tm
<0001>Tj
18.896 0 Td
<0001>Tj
18.896 0 Td
<0001>Tj
ET
70.559 790.941 456.48 0.481 re
f
BT
/C2_0 1 Tf
12 0 0 12 72.059 779.541 Tm
<0001>Tj
0 -60.955 TD
<0001>Tj
18.896 0 Td
<0001>Tj
18.896 0 Td
<0001>Tj
ET
70.559 60.501 438.48 0.481 re
f
BT
/TT0 1 Tf
12 0 0 12 512.1591 49.701 Tm
(99)Tj
ET
q
512.159 37.101 13.38 23.82 re
W n
BT
/C2_0 1 Tf
12 0 0 12 525.5067 49.701 Tm
<0001>Tj
ET
Q
BT
/TT1 1 Tf
12 0 0 12 72.059 758.721 Tm
[(PUBLICA)-1(TIONS)]TJ
( )Tj
/C2_0 1 Tf
0 -2.74 TD
<0001>Tj
/TT0 1 Tf
0.001 Tc 0.298 Tw 10.98 0 0 10.98 72.059 702.921 Tm
[(Genom)-1(e int)1(egrit)1(y of)1( m)-1(yeloprolif)1(erat)1(ive neoplasm)-1(s in chronic )]TJ
28.932 0 Td
(phase and during disease )Tj
-0.001 Tw -28.932 -1.153 Td
(progression.)Tj
0 Tc 0 Tw 5.513 0 Td
( )Tj
/TT2 1 Tf
0.001 Tc 0.165 Tw -5.513 -1.153 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
4.73 0 Td
[(*,)1( Harut)1(yunyan A*,)1( Berg T,)1( Gisslinger B,)1( Schalling M)-5(,)1( Bagienski K,)1( Olcaydu D,)1( )]TJ
0.117 Tw -4.73 -1.153 Td
[(Passam)-2(ont)1(i F,)1( Rum)-2(i E,)1( Piet)1(ra D,)1( J\344ger R,)1( Pieri L,)1( Guglielm)-2(elli P,)1( I)1(acobucci I)1(,)1( M)-5(art)1(inelli G,)1( )]TJ
-0.001 Tw 0 -1.148 TD
[(Cazzola M)-5(,)1( Vannucchi AM)-5(,)1( Gisslinger H,)]TJ
18.048 0 Td
( Kralovics R.)Tj
0 Tc 0 Tw 5.623 0 Td
( )Tj
0.001 Tc -0.001 Tw -23.67 -1.153 Td
[(Blood.)1( 2011 Jul 7;)1(118\(1\):)1(167)]TJ
0 Tc 0 Tw 12.866 0 Td
(-)Tj
0.001 Tc -0.001 Tw 0.334 0 Td
[(76.)1( )]TJ
0 Tc 0 Tw 1.671 0 Td
( )Tj
/TT0 1 Tf
-14.871 -1.153 Td
( )Tj
0.001 Tc -0.001 Tw 0 -1.153 TD
[(p53 lesions in leukem)-1(ic t)1(ransf)1(orm)-1(at)1(ion.)]TJ
0 Tc 0 Tw 17.319 0 Td
( )Tj
/TT3 1 Tf
0.001 Tc -0.001 Tw -17.319 -1.153 Td
[(Harut)1(yunyan A,)1( )]TJ
/TT2 1 Tf
7.183 0 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
4.564 0 Td
[(,)1( Cazzola M)-5(,)1( Kralovics R.)]TJ
0 Tc 0 Tw 11.194 0 Td
( )Tj
0.001 Tc -0.001 Tw -22.942 -1.148 Td
[(N Engl J M)-5(ed.)1( 2011 Feb 3;)1(364\(5\):)1(488)]TJ
0 Tc 0 Tw 16.767 0 Td
(-)Tj
0.001 Tc -0.001 Tw 0.334 0 Td
[(90.)1( )]TJ
0 Tc 0 Tw 1.671 0 Td
( )Tj
/TT0 1 Tf
-18.772 -1.153 Td
( )Tj
0.001 Tc 0.109 Tw T*
[(Rare germ)-1(line variant)1(s in regions of)1( loss of)1( het)1(erozygosit)1(y m)-1(ay inf)1(luence c)]TJ
34.178 0 Td
[(linical course of)1( )]TJ
-0.001 Tw -34.178 -1.153 Td
[(hem)-1(at)1(ological m)-1(alignancies.)]TJ
0 Tc 0 Tw 12.586 0 Td
( )Tj
/TT3 1 Tf
0.001 Tc -0.001 Tw -12.586 -1.153 Td
[(Harut)1(yunyan A,)1( Gisslinger B,)1( )]TJ
/TT2 1 Tf
13.141 0 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
4.564 0 Td
[(,)1( Berg T,)1( Bagienski K,)1( Gisslinger H,)1( Kralovics R.)]TJ
0 Tc 0 Tw 21.323 0 Td
( )Tj
0.001 Tc -0.001 Tw -39.028 -1.153 Td
[(Leukem)-2(ia.)1( 2011 Nov;)1(25\(11\):)1(1782)]TJ
0 Tc 0 Tw 14.872 0 Td
(-)Tj
0.001 Tc -0.001 Tw 0.334 0 Td
(4.)Tj
/TT0 1 Tf
0 Tc 0 Tw 0.835 0 Td
( )Tj
( )Tj
-16.041 -1.148 Td
( )Tj
0.001 Tc -0.001 Tw 0 -1.153 TD
[(Frequent)1( delet)1(ions of)1( JARI)1(D2 in leukem)-1(ic t)1(ransf)1(orm)-1(at)1(ion of)1( chronic m)-1(yeloid )]TJ
33.745 0 Td
[(m)-1(alignancies.)]TJ
0 Tc 0 Tw 6.126 0 Td
( )Tj
/TT3 1 Tf
0.001 Tc 0.069 Tw -39.871 -1.153 Td
[(Puda A,)1( M)-5(ilosevic JD,)1( Berg T,)1( )]TJ
/TT2 1 Tf
14.007 0 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
4.634 0 Td
[(,)1( Harut)1(yunyan AS,)1( Gisslinger B,)1( Rum)-2(i E,)1( Piet)1(ra D,)1( )]TJ
0.165 Tw -18.64 -1.153 Td
[(M)-5(alcovat)1(i L,)1( Elena C,)1( Doubek M)-5(,)1( St)1(eurer M)-5(,)1( Tosic N,)1( Pavlovic S,)1( Guglielm)-2(elli P,)1( Pieri L,)1( )]TJ
-0.001 Tw 0 -1.153 TD
[(Vannucchi AM)-5(,)1( Gisslinger H,)1( Cazzola M)-5(,)1( Kralovics R.)]TJ
0 Tc 0 Tw 23.67 0 Td
( )Tj
0.001 Tc -0.001 Tw -23.67 -1.148 Td
[(Am)-2( J Hem)-2(at)1(ol)]TJ
6.294 0 Td
[(.)1( 2012 M)-5(ar;)1(87\(3\):)1(245)]TJ
0 Tc 0 Tw 9.36 0 Td
(-)Tj
0.001 Tc -0.001 Tw 0.334 0 Td
(50)Tj
0 Tc 0 Tw (.)Tj
( )Tj
-15.988 -1.153 Td
( )Tj
/TT0 1 Tf
0.001 Tc -0.001 Tw 0 -1.153 TD
[(Clinical signif)1(icance of)1( genet)1(ic aberrat)1(ions in secondary acut)1(e m)-1(yeloid leukem)-1(ia)]TJ
0.137 0.122 0.125 scn
/C2_0 1 Tf
0 Tc 0 Tw 15.96 0 0 15.96 460.3407 424.641 Tm
<0001>Tj
0 0 0 scn
/TT3 1 Tf
0.001 Tc 0.01 Tw 10.98 0 0 10.98 72.059 411.981 Tm
[(M)-5(ilosevic JD,)1( Puda A,)1( M)-5(alcovat)1(i L,)1( Berg T,)1( Hof)1(bauer M)-5(,)1( St)1(ukalov A,)1( )]TJ
/TT2 1 Tf
30.481 0 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
[(,)1( Harut)1(yunyan )]TJ
0.133 Tw -30.481 -1.153 Td
[(AS,)1( Gisslinger H,)1( Gisslinger B,)1( Burjanivova T,)1( Rum)-2(i E,)1( )]TJ
25.593 0 Td
[(Piet)1(ra D,)1( Elena C,)1( Vannucchi AM)-5(,)1( )]TJ
0.106 Tw -25.593 -1.148 Td
[(Doubek M)-5(,)1( Dvorakova D,)1( Robesova B,)1( W)-1(ieser R,)1( Koller E,)1( Suvajdzic N,)1(Tom)-2(in D,)1( Tosic N,)1( )]TJ
-0.001 Tw T*
[(Colinge J,)1( Racil Z,)1( St)1(eurer M)-5(,)1( Pav)]TJ
15.092 0 Td
[(lovic S,)1( Cazzola M)-5(,)1( Kralovics R)]TJ
0 Tc 0 Tw 13.867 0 Td
( )Tj
0.001 Tc -0.001 Tw -28.959 -1.153 Td
[(Am)-2( J Hem)-2(at)1(ol.)1( 2012,)1( )]TJ
9.636 0 Td
[(Nov;)1(87\(11\):)1(1010)]TJ
0 Tc 0 Tw 7.463 0 Td
(-)Tj
0.001 Tc -0.001 Tw 0.334 0 Td
(6.)Tj
0 Tc 0 Tw 0.836 0 Td
( )Tj
-18.268 -1.153 Td
( )Tj
/TT0 1 Tf
0.001 Tc 0.053 Tw 0 -1.153 TD
(An RNA)Tj
0 Tc 0 Tw 3.673 0 Td
(-)Tj
0.001 Tc 0.053 Tw 0.334 0 Td
[(Seq st)1(rat)1(egy t)1(o det)1(ect)1( t)1(h)]TJ
11.076 0 Td
[(e com)-1(plet)1(e coding and non)]TJ
0 Tc 0 Tw 12.247 0 Td
(-)Tj
0.001 Tc 0.053 Tw 0.334 0 Td
[(coding t)1(ranscript)1(om)-1(e including )]TJ
-0.001 Tw -27.662 -1.153 Td
[(f)1(ull)]TJ
0 Tc 0 Tw (-)Tj
0.001 Tc -0.001 Tw 1.614 0 Td
[(lengt)1(h im)-1(print)1(ed m)-1(acro ncRNAs.)]TJ
0 Tc 0 Tw 14.422 0 Td
( )Tj
/TT3 1 Tf
0.001 Tc 0.265 Tw -16.036 -1.148 Td
[(Huang R,)1( Jarit)1(z M)-5(,)1( Guenzl P,)1( Vlat)1(kovic I)1(,)1( Som)-2(m)-2(er A,)1( Tam)-2(ir I)1(M)-5(,)1( M)-5(arks H,)1( )]TJ
/TT2 1 Tf
36.194 0 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
0 Tc 0 Tw 4.83 0 Td
(, )Tj
0.001 Tc -0.001 Tw -41.024 -1.153 Td
[(Kralovics R,)1( St)1(unnenberg HG,)1( Barlow)-1( DP,)1( Pauler FM)-5(.)]TJ
0 Tc 0 Tw 23.891 0 Td
( )Tj
0.001 Tc -0.001 Tw -23.891 -1.153 Td
[(PLoS One.)1( 2011;)1( 6\(11\):)1(e27288)]TJ
0 Tc 0 Tw 13.925 0 Td
( )Tj
-13.925 -1.153 Td
( )Tj
/TT0 1 Tf
0.001 Tc 0.192 Tw T*
[(I)1(dent)1(if)1(icat)1(ion of)1( genom)-1(ic aberrat)1(ions associat)1(ed wit)1(h disease t)1(ransf)1(orm)-1(at)1(ion by m)-1(eans of)1( )]TJ
-0.001 Tw 0 -1.148 TD
(high)Tj
0 Tc 0 Tw (-)Tj
0.001 Tc -0.001 Tw 2.228 0 Td
[(resolut)1(ion SNP array analysis in pat)1(ient)1(s wit)1(h m)-1(yeloprolif)1(erat)1(ive neoplasm)-1(.)]TJ
0 Tc 0 Tw 33.078 0 Td
( )Tj
/TT3 1 Tf
0.001 Tc 0.232 Tw -35.306 -1.153 Td
[(Rum)-2(i E,)1( Harut)1(yunyan A,)1( Elena C,)1( Piet)1(ra D,)1( )]TJ
/TT2 1 Tf
21.187 0 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
4.797 0 Td
[(,)1( Bagienski K,)1( Berg T,)1( Caset)1(t)1(i I)1(,)1( )]TJ
0 Tc 0 Tw -25.984 -1.153 Td
(P)Tj
0.001 Tc -0.001 Tw 0.668 0 Td
[(ascut)1(t)1(o C,)1( Passam)-2(ont)1(i F,)1( Kralovics R,)1( Cazzola M)-5(.)]TJ
0 Tc 0 Tw 22.109 0 Td
( )Tj
0.001 Tc -0.001 Tw -22.777 -1.153 Td
[(Am)-2( J Hem)-2(at)1(ol.)1( 2011 Dec;)1(86\(12\):)1(974)]TJ
0 Tc 0 Tw 16.263 0 Td
(-)Tj
0.334 0 Td
[(9)-1(. )]TJ
1.114 0 Td
( )Tj
/TT0 1 Tf
-17.71 -1.153 Td
( )Tj
0.001 Tc -0.001 Tw 0 -1.153 TD
[(Delet)1(ions of)1( t)1(he t)1(ranscript)1(ion f)1(act)1(or I)1(karos in m)-1(yeloprolif)1(erat)1(ive neoplasm)-1(s.)]TJ
0 Tc 0 Tw 33.077 0 Td
( )Tj
/TT3 1 Tf
0.001 Tc 0.006 Tw -33.077 -1.148 Td
[(J\344ger R,)1( Gisslinger H,)1( Passam)-2(ont)1(i F,)1( Rum)-2(i E,)1( Berg T,)1( Gisslinger B,)1( Piet)1(ra D,)1( Harut)1(yunyan A)]TJ
0 Tc 0 Tw 41.024 0 Td
(, )Tj
/TT2 1 Tf
0.001 Tc -0.001 Tw -41.024 -1.153 Td
[(Kl)1(am)-1(pfl)1( T)]TJ
/TT3 1 Tf
4.564 0 Td
[(,)1( Olcaydu D,)1( Cazzola M)-5(,)1( Kralovics R.)]TJ
0 Tc 0 Tw 16.428 0 Td
( )Tj
0.001 Tc -0.001 Tw -20.992 -1.153 Td
[(Leukem)-2(ia.)1( 2010 Jul;)1(24\(7\):)1(1290)]TJ
0 Tc 0 Tw 13.814 0 Td
(-)Tj
0.001 Tc -0.001 Tw 0.334 0 Td
(8.)Tj
0 Tc 0 Tw 0.835 0 Td
( )Tj
/TT0 1 Tf
12 0 0 12 72.059 132.741 Tm
( )Tj
0.001 Tc -0.001 Tw 10.98 0 0 10.98 434.4384 96.141 Tm
[(*equal cont)1(ribut)1(ion)]TJ
0 Tc 0 Tw 8.299 0 Td
( )Tj
ET
endstream
endobj
63 0 obj
<>
endobj
64 0 obj
<>
endobj
66 0 obj
<>
endobj
78 0 obj
<>
endobj
65 0 obj
<>
endobj
84 0 obj
<>
endobj
85 0 obj
<>stream
HVPT%,x
ˊ1(,EQ+>҅!.
1$vlW룙vTIzW"QciĚLk4FQkj4ƱNޞ t{w99(YuY'zZܨ9O θ0_U;-+7|&`q_wvw:|gXlg~#}uMӯۘ?g_8[OM=kګu=a/lhK
e//ST|̌@V<4V[XxDdT{lϸWbRrJj>Ui3dr<`C6:\L)YciGrmA$Wㆩ.4>9
{+ ;)f?6cK萨GQ";!iNz#:$k(HF!<.jܠbZ%HEa3і$K=:$; Ji;.Qи4`:{njl Z#ųb)(jsx"(ޡ2IYkp/b a\x9OI5!fzŢVra'b2fxۀ"Wp{q;Q@_Xu,R2 *46ѿMVqGZd&EyS)Q+H#(5|F)crVa\65l~ .S4S}[zNWlR{H4(Whcٗ1OgDp=
{܁y>\8/;S"lʡTFTKL/jZKzi/Gsޥt[,"E+,Q+Vb':%>g9qYweOf9QVʅI6(\%SR~lSv++הHj˖_Z.[.[a[G[Z}֟[۬٤Vc{%0ia;#>J0>/vT~A2 ϖRD&^#AI_k8Ce;mAUbhRb{ʛ=jTN+R\Ba+baQ:l8)rQl\5%Nڈ/q#b.=biyUDI'.(K#jv,b?(Y#[uF+OB&㨤w& hJqMB<;W(Vي9[in[[]2`Qz'6:ea3^I\ӻo15pb&iQʡLL0Ox7 6I^tVyq3
Ǝ?*odÞ,Ǡ2kԾ靚+!>g=>dDxj\ZG3<8M^,*~FW=!3aeAeA%|;TEFenZ=9D+!3iiCu%T0G/yܯ[
.v%.5~&i6Gw>;Af_
?ܙMhv>Lul<-ͬʶT1XUTAA\Ss&ay{Gm
ϗetb\sRCXlCէӏ=W\)/@aEf-U2_ݲ!K%rhx9*?#p9(86gK*_ED
_!2.#^ \zB<
Y5,^ާ}4 EPHAP6f0`Dg2u H+3_B4MAnGăɁNNg KɱQW&2ÞsNLpew`xB,pYxuZ5y%vGY6+J/RDO$cU ZC--n&9_ihh.
11Fl03ӇRwtMYjqk@ҍNI!ukiRūNu]|?*Rw"52fu\Nv`Nwgt/~WϬ8V6),pImyXyC{wMoJ]SmW[կ}ǜԆYԮ,z6OJn/"uKם";=+GzI(F11J~bh0:oI) ~+|F"2NG7oӵSx^o|͎Tyԅ[ţRė^R14:ʊ(FԆC(-%*UhM:#ՈbD8sqD6oi̶fN}:00.Fj+aAZ^+Z0-hJc68h@Ԧ$ݓ@Kb9JyI2GwޟcMC,4
=!@ҳ:Md]E^"̓UxeZt+חϮvĭtɯOoW{~RlXW=VX,u7AEPM'ZJC3bd[Q rX1g :Kf೨ojV>)l"`o˱,^i߳ذ5w0ۖu&-"ፈ3b+b6wȓT
q\؉jЙBN.WUCk݃%(FS3!nc@ԭ#O a جnyh~#xHR}K(Da/nLG=0=nEоod kU7vFƀ-gUGb~2̊]{6ڥ56*lږL2YrFVgNXjkM2:H4^nUL55T; @q 쾕]>wOWo#X;x˽mS